ID

42960

Beschreibung

see http://clinicaltrials.gov/ct2/show/study/NCT00048295 ISIS 2302 is an antisense oligonucleotide drug that reduces the production of a specific protein called intercellular adhesion molecule (ICAM-1), a substance that plays a significant role in the increase of inflammation. People with Crohn’s disease have been shown to over-produce ICAM-1 in their gut tissues. Alicaforsen works by blocking ICAM-1 messenger RNA, the “instruction” molecule that is required for the production of ICAM-1 protein. This trial will examine effects of alicaforsen delivered by 2-hour intravenous infusion over a four-week period, compared to a placebo. Patients may remain on stable background 5-ASA, antibiotic, or immunosuppressive drugs, and prednisone (or equivalent) at </= 30 mg per day.

Link

http://clinicaltrials.gov/ct2/show/study/NCT00048295

Stichworte

  1. 14.11.11 14.11.11 -
  2. 14.11.11 14.11.11 -
  3. 22.03.14 22.03.14 - Martin Dugas
  4. 17.09.21 17.09.21 -
Hochgeladen am

17. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility NCT00048295 Crohns Disease

Eligibility NCT00048295

  1. StudyEvent: Eligibility
    1. Eligibility NCT00048295
Inclusion
Beschreibung

Inclusion

Age at least 12 years
Beschreibung

Age

Datentyp

integer

Maßeinheiten
  • [years]
Alias
UMLS CUI-1
C0001779
[years]
Weight at least 36 kg
Beschreibung

Weight

Datentyp

boolean

Alias
UMLS CUI-1
C0005910
CDAI score of 220 - 400
Beschreibung

CDAI score

Datentyp

boolean

Alias
UMLS CUI-1
C0451071
Documentation of Crohns disease activity by endoscopy, biopsy or imaging in the last 2 years
Beschreibung

Active Crohns disease

Datentyp

boolean

Alias
UMLS CUI-1
C0010346
No TNF-alpha inhibitor treatment for three months prior to first study drug infusion
Beschreibung

No TNF-alpha inhibitor

Datentyp

boolean

Alias
UMLS CUI-1
C1518422
UMLS CUI-2
C1456820
UMLS CUI-3
C0021469
Exclusion
Beschreibung

Exclusion

Known severe, fixed, symptomatic stenosis of the small or large intestine with significant dilation
Beschreibung

Severe intestinal stenosis

Datentyp

boolean

Alias
UMLS CUI-1
C0521587
Extensive external fistulization (> 3 external fistulae which are expressible with gentle compression); colostomy or ileostomy
Beschreibung

External fistulization

Datentyp

boolean

Alias
UMLS CUI-1
C0016169
Active infection, including infectious colitis, or infection with HIV, Hepatitis B or Hepatitis C
Beschreibung

Infection

Datentyp

boolean

Alias
UMLS CUI-1
C0009450
Malignancy within 3 years or poorly controlled medical illness
Beschreibung

Malignancy

Datentyp

boolean

Alias
UMLS CUI-1
C0006826
Requires intravenous heparin therapy or with a history of a bleeding problem
Beschreibung

Bleeding problem

Datentyp

boolean

Alias
UMLS CUI-1
C1458140

Ähnliche Modelle

Eligibility NCT00048295

  1. StudyEvent: Eligibility
    1. Eligibility NCT00048295
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inclusion
Age
Item
Age at least 12 years
integer
C0001779 (UMLS CUI-1)
Weight
Item
Weight at least 36 kg
boolean
C0005910 (UMLS CUI-1)
CDAI score
Item
CDAI score of 220 - 400
boolean
C0451071 (UMLS CUI-1)
Active Crohns disease
Item
Documentation of Crohns disease activity by endoscopy, biopsy or imaging in the last 2 years
boolean
C0010346 (UMLS CUI-1)
No TNF-alpha inhibitor
Item
No TNF-alpha inhibitor treatment for three months prior to first study drug infusion
boolean
C1518422 (UMLS CUI-1)
C1456820 (UMLS CUI-2)
C0021469 (UMLS CUI-3)
Item Group
Exclusion
Severe intestinal stenosis
Item
Known severe, fixed, symptomatic stenosis of the small or large intestine with significant dilation
boolean
C0521587 (UMLS CUI-1)
External fistulization
Item
Extensive external fistulization (> 3 external fistulae which are expressible with gentle compression); colostomy or ileostomy
boolean
C0016169 (UMLS CUI-1)
Infection
Item
Active infection, including infectious colitis, or infection with HIV, Hepatitis B or Hepatitis C
boolean
C0009450 (UMLS CUI-1)
Malignancy
Item
Malignancy within 3 years or poorly controlled medical illness
boolean
C0006826 (UMLS CUI-1)
Bleeding problem
Item
Requires intravenous heparin therapy or with a history of a bleeding problem
boolean
C1458140 (UMLS CUI-1)

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video